These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27693615)

  • 21. Angioimmunoblastic T-cell Lymphomas With the RHOA p.Gly17Val Mutation Have Classic Clinical and Pathologic Features.
    Ondrejka SL; Grzywacz B; Bodo J; Makishima H; Polprasert C; Said JW; Przychodzen B; Maciejewski JP; Hsi ED
    Am J Surg Pathol; 2016 Mar; 40(3):335-41. PubMed ID: 26574844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ccpg1, a novel scaffold protein that regulates the activity of the Rho guanine nucleotide exchange factor Dbs.
    Kostenko EV; Olabisi OO; Sahay S; Rodriguez PL; Whitehead IP
    Mol Cell Biol; 2006 Dec; 26(23):8964-75. PubMed ID: 17000758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant alternative splicing of RHOA is associated with loss of its expression and activity in diffuse-type gastric carcinoma cells.
    Miyamoto S; Nagamura Y; Nakabo A; Okabe A; Yanagihara K; Fukami K; Sakai R; Yamaguchi H
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1942-1947. PubMed ID: 29247652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RhoA mutations identified in diffuse gastric cancer.
    Zhou J; Hayakawa Y; Wang TC; Bass AJ
    Cancer Cell; 2014 Jul; 26(1):9-11. PubMed ID: 25026207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma.
    Yoo HY; Sung MK; Lee SH; Kim S; Lee H; Park S; Kim SC; Lee B; Rho K; Lee JE; Cho KH; Kim W; Ju H; Kim J; Kim SJ; Kim WS; Lee S; Ko YH
    Nat Genet; 2014 Apr; 46(4):371-5. PubMed ID: 24584070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid rafts of primary endothelial cells are essential for Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-induced phosphatidylinositol 3-kinase and RhoA-GTPases critical for microtubule dynamics and nuclear delivery of viral DNA but dispensable for binding and entry.
    Raghu H; Sharma-Walia N; Veettil MV; Sadagopan S; Caballero A; Sivakumar R; Varga L; Bottero V; Chandran B
    J Virol; 2007 Aug; 81(15):7941-59. PubMed ID: 17507466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ARHGAP-RhoA signaling provokes homotypic adhesion-triggered cell death of metastasized diffuse-type gastric cancer.
    Komatsu M; Ichikawa H; Chiwaki F; Sakamoto H; Komatsuzaki R; Asaumi M; Tsunoyama K; Fukagawa T; Matsushita H; Boku N; Matsusaki K; Takeshita F; Yoshida T; Sasaki H
    Oncogene; 2022 Oct; 41(43):4779-4794. PubMed ID: 36127398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BNIP2 extra long inhibits RhoA and cellular transformation by Lbc RhoGEF via its BCH domain.
    Soh UJ; Low BC
    J Cell Sci; 2008 May; 121(Pt 10):1739-49. PubMed ID: 18445682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity.
    Liu N; Bi F; Pan Y; Sun L; Xue Y; Shi Y; Yao X; Zheng Y; Fan D
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6239-47. PubMed ID: 15448013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BART inhibits pancreatic cancer cell invasion by inhibiting ARL2-mediated RhoA inactivation.
    Taniuchi K; Iwasaki S; Saibara T
    Int J Oncol; 2011 Nov; 39(5):1243-52. PubMed ID: 21833473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positive feedback between Dia1, LARG, and RhoA regulates cell morphology and invasion.
    Kitzing TM; Sahadevan AS; Brandt DT; Knieling H; Hannemann S; Fackler OT; Grosshans J; Grosse R
    Genes Dev; 2007 Jun; 21(12):1478-83. PubMed ID: 17575049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Choline kinase is a novel oncogene that potentiates RhoA-induced carcinogenesis.
    Ramírez de Molina A; Gallego-Ortega D; Sarmentero J; Bañez-Coronel M; Martín-Cantalejo Y; Lacal JC
    Cancer Res; 2005 Jul; 65(13):5647-53. PubMed ID: 15994937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invasion of T-lymphoma cells: cooperation between Rho family GTPases and lysophospholipid receptor signaling.
    Stam JC; Michiels F; van der Kammen RA; Moolenaar WH; Collard JG
    EMBO J; 1998 Jul; 17(14):4066-74. PubMed ID: 9670021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth.
    Murphy GA; Solski PA; Jillian SA; Pérez de la Ossa P; D'Eustachio P; Der CJ; Rush MG
    Oncogene; 1999 Jul; 18(26):3831-45. PubMed ID: 10445846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of Rho GTPases and their effectors in the secretory process of PC12 cells.
    Frantz C; Coppola T; Regazzi R
    Exp Cell Res; 2002 Feb; 273(2):119-26. PubMed ID: 11822867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent RHOA mutations in pediatric Burkitt lymphoma treated according to the NHL-BFM protocols.
    Rohde M; Richter J; Schlesner M; Betts MJ; Claviez A; Bonn BR; Zimmermann M; Damm-Welk C; Russell RB; Borkhardt A; Eils R; Hoell JI; Szczepanowski M; Oschlies I; Klapper W; Burkhardt B; Siebert R; ;
    Genes Chromosomes Cancer; 2014 Nov; 53(11):911-6. PubMed ID: 25044415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The small GTPase RhoA regulates the expression and function of the sodium channel Nav1.5 in breast cancer cells.
    Dulong C; Fang YJ; Gest C; Zhou MH; Patte-Mensah C; Mensah-Nyagan AG; Vannier JP; Lu H; Soria C; Cazin L; Mei YA; Varin R; Li H
    Int J Oncol; 2014 Feb; 44(2):539-47. PubMed ID: 24337141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. α-TEA inhibits the growth and motility of human colon cancer cells via targeting RhoA/ROCK signaling.
    Yao J; Gao P; Xu Y; Li Z
    Mol Med Rep; 2016 Sep; 14(3):2534-40. PubMed ID: 27432222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional analysis of the contribution of RhoA and RhoC GTPases to invasive breast carcinoma.
    Simpson KJ; Dugan AS; Mercurio AM
    Cancer Res; 2004 Dec; 64(23):8694-701. PubMed ID: 15574779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiRNA-125a-3p is a negative regulator of the RhoA-actomyosin pathway in A549 cells.
    Huang B; Luo W; Sun L; Zhang Q; Jiang L; Chang J; Qiu X; Wang E
    Int J Oncol; 2013 May; 42(5):1734-42. PubMed ID: 23525486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.